Kosar Malekpour

714 total citations
17 papers, 507 citations indexed

About

Kosar Malekpour is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Kosar Malekpour has authored 17 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Genetics and 5 papers in Surgery. Recurrent topics in Kosar Malekpour's work include Extracellular vesicles in disease (9 papers), Mesenchymal stem cell research (8 papers) and MicroRNA in disease regulation (3 papers). Kosar Malekpour is often cited by papers focused on Extracellular vesicles in disease (9 papers), Mesenchymal stem cell research (8 papers) and MicroRNA in disease regulation (3 papers). Kosar Malekpour collaborates with scholars based in Iran, Malaysia and Russia. Kosar Malekpour's co-authors include Ali Hazrati, Sara Soudi, Seyed Mahmoud Hashemi, Majid Ahmadi, Leila Roshangar, Rajender S. Varma, Mohammad Mahmoudi, Angelina Olegovna Zekiy, Jamshid Gholizadeh Navashenaq and Alexander Markov and has published in prestigious journals such as Journal of Controlled Release, Frontiers in Immunology and European Journal of Pharmacology.

In The Last Decade

Kosar Malekpour

17 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kosar Malekpour Iran 13 309 130 118 105 67 17 507
Xiong‐Ke Hu China 7 375 1.2× 69 0.5× 111 0.9× 64 0.6× 68 1.0× 9 562
Hyun-keun Kim South Korea 7 507 1.6× 160 1.2× 161 1.4× 93 0.9× 67 1.0× 10 730
Young Jong Ko South Korea 11 231 0.7× 226 1.7× 67 0.6× 88 0.8× 97 1.4× 16 562
Yi-Wei Liu China 7 542 1.8× 85 0.7× 208 1.8× 70 0.7× 77 1.1× 11 747
Urara Tanaka Japan 8 285 0.9× 111 0.9× 134 1.1× 95 0.9× 43 0.6× 15 493
Suchi Gupta India 12 375 1.2× 95 0.7× 171 1.4× 37 0.4× 52 0.8× 18 525
Sumi Sung South Korea 4 352 1.1× 120 0.9× 124 1.1× 47 0.4× 52 0.8× 4 535
Ju‐Hyun An South Korea 10 159 0.5× 160 1.2× 69 0.6× 107 1.0× 90 1.3× 56 403
Linglu Jia China 14 254 0.8× 162 1.2× 70 0.6× 35 0.3× 54 0.8× 26 560
Aimei Song China 9 170 0.6× 97 0.7× 43 0.4× 106 1.0× 51 0.8× 22 518

Countries citing papers authored by Kosar Malekpour

Since Specialization
Citations

This map shows the geographic impact of Kosar Malekpour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosar Malekpour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosar Malekpour more than expected).

Fields of papers citing papers by Kosar Malekpour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosar Malekpour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosar Malekpour. The network helps show where Kosar Malekpour may publish in the future.

Co-authorship network of co-authors of Kosar Malekpour

This figure shows the co-authorship network connecting the top 25 collaborators of Kosar Malekpour. A scholar is included among the top collaborators of Kosar Malekpour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosar Malekpour. Kosar Malekpour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rahimi, Ali, Ali Hazrati, Kosar Malekpour, et al.. (2025). Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota. Biomedicine & Pharmacotherapy. 186. 118014–118014. 8 indexed citations
2.
Hazrati, Ali, Kosar Malekpour, Hossein Khorramdelazad, Samira Rajaei, & Seyed Mahmoud Hashemi. (2024). Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules. Biomarker Research. 12(1). 35–35. 21 indexed citations
3.
Hazrati, Ali, et al.. (2024). Mesenchymal stem cell application in pulmonary disease treatment with emphasis on their interaction with lung-resident immune cells. Frontiers in Immunology. 15. 1469696–1469696. 1 indexed citations
4.
Abdollahi, Maryam, Sanaz Abbaspour‐Aghdam, Ali Hazrati, et al.. (2023). The effect of probiotics on immune responses and their therapeutic application: A new treatment option for multiple sclerosis. Biomedicine & Pharmacotherapy. 159. 114195–114195. 24 indexed citations
5.
Hazrati, Ali, Kosar Malekpour, Arezou Khosrojerdi, et al.. (2023). Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches. Frontiers in Immunology. 14. 1280601–1280601. 12 indexed citations
6.
Malekpour, Kosar, Ali Hazrati, Sara Soudi, & Seyed Mahmoud Hashemi. (2023). Mechanisms behind therapeutic potentials of mesenchymal stem cell mitochondria transfer/delivery. Journal of Controlled Release. 354. 755–769. 49 indexed citations
7.
Hazrati, Ali, Hadi Esmaeili Gouvarchin Ghaleh, Nematollah Jonaidi Jafari, et al.. (2023). Exosomes from Adipose Tissue-derived Mesenchymal Stem Cells Induce Regulatory T Cells in COVID‐19 Patients. Iranian Journal of Allergy Asthma and Immunology. 22(3). 233–244. 5 indexed citations
8.
9.
Hazrati, Ali, et al.. (2023). The potential application of encapsulated exosomes: A new approach to increase exosomes therapeutic efficacy. Biomedicine & Pharmacotherapy. 162. 114615–114615. 30 indexed citations
10.
Malekpour, Kosar, Ali Hazrati, Arezou Khosrojerdi, Leila Roshangar, & Majid Ahmadi. (2023). An overview to nanocellulose clinical application: Biocompatibility and opportunities in disease treatment. Regenerative Therapy. 24. 630–641. 14 indexed citations
11.
Hazrati, Ali, Sara Soudi, Kosar Malekpour, et al.. (2022). Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications. Biomarker Research. 10(1). 30–30. 109 indexed citations
12.
Hazrati, Ali, Kosar Malekpour, Sara Soudi, & Seyed Mahmoud Hashemi. (2022). Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles Application in Acute and Chronic Inflammatory Liver Diseases: Emphasizing on the Anti-Fibrotic and Immunomodulatory Mechanisms. Frontiers in Immunology. 13. 865888–865888. 38 indexed citations
13.
Hazrati, Ali, Kosar Malekpour, Sara Soudi, & Seyed Mahmoud Hashemi. (2022). Mesenchymal stromal/stem cells spheroid culture effect on the therapeutic efficacy of these cells and their exosomes: A new strategy to overcome cell therapy limitations. Biomedicine & Pharmacotherapy. 152. 113211–113211. 30 indexed citations
14.
Hazrati, Ali, Kosar Malekpour, Sara Soudi, & Seyed Mahmoud Hashemi. (2022). CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations. Biomedicine & Pharmacotherapy. 156. 113943–113943. 47 indexed citations
15.
Abbaspour‐Aghdam, Sanaz, Ali Hazrati, Samaneh Abdolmohammadi‐Vahid, et al.. (2022). Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function. European Journal of Pharmacology. 933. 175267–175267. 15 indexed citations
16.
Ghaleh, Hadi Esmaeili Gouvarchin, Nematollah Jonaidi Jafari, Ali Hazrati, et al.. (2022). Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19. Pathology - Research and Practice. 241. 154280–154280. 13 indexed citations
17.
Malekpour, Kosar, Ali Hazrati, Alexander Markov, et al.. (2021). The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes for Orthopedic Diseases Treatment. Stem Cell Reviews and Reports. 18(3). 933–951. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026